Pitney Bowes Inc., operates as a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to small businesses, large enterprises, and government entities around the world. It operates through SendTech Solutions and Presort Services segments. The SendTech Solutions segment provides physical and digital shipping and mailing technology solutions, and other applications for sending, tracking and receiving of letters, parcels and flats, supplies, and maintenance services, as well as financing alternatives to finance equipment and product purchases. The Presort Services segment offers mail sortation services, which allow clients to qualify volumes of first-class mail, marketing mail, marketing mail flats, and bound printed matter for postal workshare discounts. It markets its products, solutions, and services through direct and inside sales force, global and regional partner channels, direct mailings, and digital channels. The company was formerly known as Pitney Bowes Postage Meter Company. Pitney Bowes Inc. was incorporated in 1920 and is headquartered in Stamford, Connecticut.

Pitney Bowes Inc.

Paradigm Biopharmaceuticals ( ($AU:PAR) ) has issued an update. Paradigm Biopharmaceuticals has disclosed a change in the interests of director Pau...

Paradigm Biopharmaceuticals Director Converts Options Into Shares

Paradigm Biopharmaceuticals ( ($AU:PAR) ) has provided an update. Paradigm Biopharmaceuticals has applied to the ASX for quotation of 176,880 new o...

Paradigm Biopharmaceuticals Seeks ASX Quotation for Additional Ordinary Shares

Paradigm Biopharmaceuticals ( ($AU:PAR) ) just unveiled an announcement. Paradigm Biopharmaceuticals reported continued operational progress in the...

Paradigm Expands Global Phase 3 Knee Osteoarthritis Trial as Peer-Reviewed Data Bolster iPPS Case

An announcement from Paradigm Biopharmaceuticals ( ($AU:PAR) ) is now available. Paradigm Biopharmaceuticals has applied for quotation on the ASX o...

Paradigm Biopharmaceuticals Seeks ASX Quotation for Nearly 5 Million New Shares

The latest announcement is out from Paradigm Biopharmaceuticals ( ($AU:PAR) ). Paradigm Biopharmaceuticals has advised holders of its PAROA quoted ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PBI	$10.37	-1.57%	945.16K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PBI	$10.37	-1.6%	945.16K
3
4
5
6

PBI

PBI

No Data Available

Get Pitney Bowes Inc. Data in Excel

Get Pitney Bowes Inc. Data in Excel